Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

SIMPLE SUMMARY: Immunotherapy using immune checkpoint inhibitors (ICIs) (e.g., programmed cell death protein-1 (PD-1) inhibitors) combined with molecular targeted agents has been evaluated in clinical trials and has shown potential synergic effects and superior efficacy in unresectable hepatocellula...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Hsueh-Chien, Lee, Yang-Cheng, Chang, Ting-Tsung, Lin, Yih-Jyh, Wu, Hung-Tsung, Wang, Chung-Teng, Chen, Chiung-Yu, Chen, Po-Jun, Hsieh, Ming-Tsung, Lin, Sheng-Hsiang, Chen, Shang-Hung, Chuang, Chiao-Hsiung, Wu, I-Chin, Hong, Tzu-Chun, Wu, Juei-Seng, Han, Meng-Zhi, Chen, Wei-Ting, Chiang, Chien-Ming, Hung, Kuan-Kai, Kuo, Hsin-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913272/
https://www.ncbi.nlm.nih.gov/pubmed/36765812
http://dx.doi.org/10.3390/cancers15030854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913272/
https://www.ncbi.nlm.nih.gov/pubmed/36765812
http://dx.doi.org/10.3390/cancers15030854

Ejemplares similares